Privi Speciality Chemicals Limited — Investor Meet, 03-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Privi Speciality Chemicals delivered strong Q1 FY27 financial results: Revenue grew 19.22% YoY to Rs. 666 Cr, total income was up 20.01% YoY to Rs. 681.42 Cr, and EBITDA increased 18.73% YoY to Rs. 167.47 Cr, with margins at ~24.58%. PAT rose to Rs. 83.2 Cr.

Management is confident in reaching its Rs. 5,000 Cr revenue and Rs. 1,000 Cr+ EBITDA vision within 3-4 years. Growth is driven by ongoing capacity expansion (Phase 1 to 54,000 MT by Sep '26), introduction of new specialty products like Maltol and Ethylene Brassylate, and scaling the PRIGIV JV which reported Rs. 18 Cr revenue. The company's balance sheet remains healthy, with net debt at Rs. 865 Cr.